Gastrointestinal Stromal Tumors research hub

A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib

This study compares two treatments, ripretinib and sunitinib, for advanced GIST (a type of cancer) in patients who have already been treated with imatinib. It aims to see which treatment works best.